Affinity Asset Advisors, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$1.94B
Q ending 2026-03-31
Prior quarter
$1.76B
Q ending 2025-12-31
Change
+10.3% QoQ · +84.8% YoY
Positions
105
reported holdings
Largest positions
Top 100 of 105 reported positions by value, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| State Str Spdr S&P 500 Etf T | SPY | Put | $130.1M | 200K |
| Apogee Therapeutics Inc | APGE | Shares | $108.2M | 1.3M |
| Xenon Pharmaceuticals Inc | XENE | Shares | $97.4M | 1.7M |
| Erasca Inc | ERAS | Shares | $86.6M | 5.3M |
| Insmed Inc | INSM | Shares | $78.5M | 480K |
| Roivant Sciences Ltd | Shares | $77.6M | 2.8M | |
| Spyre Therapeutics Inc | SYRE | Shares | $64.5M | 1.3M |
| Centessa Pharmaceuticals Plc | 260 | Shares | $55.6M | 1.4M |
| Praxis Precision Medicines I | PRAX | Shares | $54.8M | 170K |
| Anaptysbio Inc | ANAB | Shares | $52.1M | 940K |
| Alkermes Plc | Shares | $47.7M | 1.4M | |
| Cytokinetics Inc | CYTK | Shares | $46.2M | 700K |
| Abivax Sa | ABVX | Shares | $45.1M | 405K |
| Teva Pharmaceutical Inds Ltd | TEVA | Shares | $42.2M | 1.4M |
| Arcellx Inc | ACLX | Shares | $41.7M | 363K |
| Moderna Inc | MRNA | Call | $40.6M | 800K |
| Nuvalent Inc | 5AX | Shares | $30.7M | 300K |
| Terns Pharmaceuticals Inc | 430 | Shares | $29.7M | 563K |
| Dianthus Therapeutics Inc | DNTH | Shares | $29.4M | 350K |
| Lexeo Therapeutics Inc | LXEO | Shares | $29.0M | 5.1M |
| Cogent Biosciences Inc | COGT | Shares | $28.9M | 750K |
| Madrigal Pharmaceuticals Inc | MDGL | Shares | $28.8M | 55K |
| Sutro Biopharma Inc | STRO | Shares | $26.6M | 1.1M |
| Forte Biosciences Inc | FBRX | Shares | $26.2M | 1.0M |
| Oruka Therapeutics Inc | ORKA | Shares | $24.5M | 500K |
| Trevi Therapeutics Inc | TRVI | Shares | $23.9M | 2.0M |
| Ovid Therapeutics Inc | OVID | Shares | $23.6M | 10.6M |
| Enliven Therapeutics Inc | ELVN | Shares | $23.0M | 587K |
| Ascendis Pharma A/S | Shares | $21.7M | 95K | |
| Mineralys Therapeutics Inc | MLYS | Shares | $20.3M | 750K |
| Avalo Therapeutics Inc | AVTX | Shares | $20.0M | 1.3M |
| Bristol-Myers Squibb Co | BMY | Call | $18.2M | 300K |
| Protagonist Therapeutics Inc | PTGX | Shares | $18.1M | 172K |
| Celldex Therapeutics Inc New | CLDX | Shares | $15.9M | 500K |
| Zura Bio Ltd | Shares | $15.3M | 2.6M | |
| Nurix Therapeutics Inc | NRIX | Shares | $15.0M | 968K |
| Savara Inc | SVRA | Shares | $13.7M | 2.5M |
| Omeros Corp | OMER 9.5 06/15/29 | Principal | $13.2M | 6.5M |
| Perspective Therapeutics Inc | CATX | Shares | $13.2M | 3.2M |
| Helix Acquisition Corp Iii | Shares | $12.7M | 1.3M | |
| Arrowhead Pharmaceuticals In | ARWR | Shares | $12.5M | 200K |
| Damora Therapeutics Inc | DMRA | Shares | $11.7M | 450K |
| Eupraxia Pharmaceuticals Inc | EPRX | Shares | $11.5M | 1.6M |
| Alto Neuroscience Inc | ANRO | Shares | $11.2M | 500K |
| Bridgebio Pharma Inc | BBIO | Shares | $11.1M | 150K |
| Cullinan Therapeutics Inc | CGEM | Shares | $11.1M | 781K |
| Belite Bio Inc | BLTE | Shares | $10.4M | 65K |
| Wave Life Sciences Ltd | Shares | $10.2M | 1.4M | |
| Vera Therapeutics Inc | VERA | Shares | $10.1M | 250K |
| Tyra Biosciences Inc | TYRA | Shares | $9.9M | 258K |
| Revolution Medicines Inc | RVMD | Shares | $9.7M | 100K |
| Revolution Medicines Inc | RVMD | Put | $9.7M | 100K |
| Immunitybio Inc | IBRX | Put | $9.6M | 1.3M |
| Jade Biosciences Inc | JBIO | Shares | $9.0M | 640K |
| Travere Therapeutics Inc | TVTX | Shares | $8.9M | 300K |
| Newamsterdam Pharma Company | Shares | $8.8M | 275K | |
| Cogent Biosciences Inc | COGT 1.625 11/15/31 | Principal | $8.6M | 7.0M |
| Korro Bio Inc | KRRO | Shares | $8.0M | 707K |
| Celcuity Inc | CELC 2.75 08/01/31 | Principal | $7.3M | 3.0M |
| Crispr Therapeutics Ag | Shares | $7.1M | 150K | |
| Spyglass Pharma Inc | SGP | Shares | $6.5M | 250K |
| Novo-Nordisk A S | NVO | Call | $6.4M | 175K |
| Compass Pathways Plc | CMPS | Shares | $6.1M | 1.1M |
| Ibio Inc | IBIO | Shares | $5.9M | 3.1M |
| Establishment Labs Hldgs Inc | Shares | $5.7M | 100K | |
| Anteris Technologies Global | AVR | Shares | $5.1M | 912K |
| Newamsterdam Pharma Company | Shares | $4.9M | 245K | |
| Uniqure Nv | Call | $4.9M | 300K | |
| Viridian Therapeutics Inc | VRDN | Shares | $4.9M | 250K |
| Climb Bio Inc | CLYM | Shares | $4.8M | 700K |
| Rezolute Inc | RZLT | Shares | $4.7M | 1.5M |
| Sagimet Biosciences Inc | SGMT | Shares | $4.5M | 868K |
| Mbx Biosciences Inc | MBX | Shares | $4.5M | 150K |
| Taysha Gene Therapies Inc | TSHA | Shares | $4.5M | 1.0M |
| Veradermics Inc | MANE | Shares | $4.4M | 70K |
| Generate Biomedicines Inc | GENB | Shares | $4.4M | 350K |
| Dianthus Therapeutics Inc | DNTH | Call | $4.2M | 50K |
| Engene Holdings Inc | Shares | $4.2M | 610K | |
| Cg Oncology Inc | CGON | Call | $4.1M | 60K |
| Arrivent Biopharma Inc | AVBP | Shares | $4.0M | 175K |
| Relay Therapeutics Inc | RLAY | Shares | $4.0M | 400K |
| Proqr Thrapeutics N V | Shares | $4.0M | 2.5M | |
| Verrica Pharmaceuticals Inc | VRCA | Shares | $3.7M | 707K |
| Celcuity Inc | CELC | Call | $3.4M | 30K |
| Precision Biosciences Inc | DTIL | Shares | $3.3M | 598K |
| Karyopharm Therapeutics Inc | KPTI | Shares | $2.8M | 500K |
| Sol-Gel Technologies Ltd | Shares | $2.8M | 35K | |
| Crinetics Pharmaceuticals In | CRNX | Shares | $2.7M | 75K |
| Oaktree Acquisition Corp Iii | Shares | $2.7M | 250K | |
| Nextcure Inc | NXTC | Shares | $2.6M | 242K |
| Immunovant Inc | IMVT | Shares | $2.5M | 100K |
| Equillium Inc | EQ | Shares | $2.5M | 1.2M |
| Sab Biotherapeutics Inc | SABS | Shares | $2.2M | 575K |
| Corcept Therapeutics Inc | CORT | Shares | $2.0M | 50K |
| Orchestra Biomed Hldgs Inc | OBIO | Shares | $1.7M | 403K |
| Kezar Life Sciences Inc | 2KZ0 | Shares | $1.7M | 229K |
| Macrogenics Inc | MGNX | Shares | $1.4M | 500K |
| Adlai Nortye Ltd | ANL | Shares | $1.1M | 165K |
| Alector Inc | ALEC | Shares | $1.1M | 500K |
| Onkure Therapeutics Inc | OKUR | Shares | $998K | 241K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.